Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Reider

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Rheumatology (Oxford, England)|December 31, 2009
Effect of the dual endothelin receptor antagonist bosentan on Raynaud's phenomenon secondary to systemic sclerosis: a double-blind prospective, randomized, placebo-controlled pilot studyVan Anh Nguyen, Klaus Eisendle, Ingrid Gruber, et al.
The Journal of Allergy and Clinical Immunology|January 19, 2002
Dendritic cells contribute to the development of atopy by an insufficiency in IL-12 productionNorbert Reider, Daniela Reider, Susanne Ebner, et al.
BMC Urology|November 14, 2019
Langerhans cells in hypospadias: an analysis of Langerin (CD207) and HLA-DR on epidermal sheets and full thickness skin sectionsBernhard Haid, Daniela Reider, Felix Nägele, et al.
Journal of Leukocyte Biology|December 19, 2002
Monocyte-derived dendritic cells release neopterinBarbara Wirleitner, Daniela Reider, Susanne Ebner, et al.
Experimental Dermatology|October 28, 2014
Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptorsPatrizia Stoitzner, Sandra Schaffenrath, Christoph H Tripp, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 30, 2020
Klaus Eisendle, Georg Weinlich, Susanne Ebner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 16, 2020
Combining chemotherapy and autologous peptide-pulsed dendritic cells provides survival benefit in stage IV melanoma patientsKlaus Eisendle, Georg Weinlich, Susanne Ebner, et al.
Experimental Dermatology|May 9, 2025
Blocking of IL-4/IL-13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton SyndromeStefan Blunder, Natascha Hermann-Kleiter, Rita Mahmuti, et al.
The Journal of Investigative Dermatology|June 30, 2015
Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma ModelDavid G Mairhofer, Daniela Ortner, Christoph H Tripp, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Rheumatology (Oxford, England)|December 31, 2009
Effect of the dual endothelin receptor antagonist bosentan on Raynaud's phenomenon secondary to systemic sclerosis: a double-blind prospective, randomized, placebo-controlled pilot studyVan Anh Nguyen, Klaus Eisendle, Ingrid Gruber, et al.
The Journal of Allergy and Clinical Immunology|January 19, 2002
Dendritic cells contribute to the development of atopy by an insufficiency in IL-12 productionNorbert Reider, Daniela Reider, Susanne Ebner, et al.
BMC Urology|November 14, 2019
Langerhans cells in hypospadias: an analysis of Langerin (CD207) and HLA-DR on epidermal sheets and full thickness skin sectionsBernhard Haid, Daniela Reider, Felix Nägele, et al.
Journal of Leukocyte Biology|December 19, 2002
Monocyte-derived dendritic cells release neopterinBarbara Wirleitner, Daniela Reider, Susanne Ebner, et al.
Experimental Dermatology|October 28, 2014
Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptorsPatrizia Stoitzner, Sandra Schaffenrath, Christoph H Tripp, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 30, 2020
Klaus Eisendle, Georg Weinlich, Susanne Ebner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 16, 2020
Combining chemotherapy and autologous peptide-pulsed dendritic cells provides survival benefit in stage IV melanoma patientsKlaus Eisendle, Georg Weinlich, Susanne Ebner, et al.
Experimental Dermatology|May 9, 2025
Blocking of IL-4/IL-13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton SyndromeStefan Blunder, Natascha Hermann-Kleiter, Rita Mahmuti, et al.
The Journal of Investigative Dermatology|June 30, 2015
Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma ModelDavid G Mairhofer, Daniela Ortner, Christoph H Tripp, et al.
Pageof 1